Lapointe V - Search Results

1

Using a Weekly Patient-Reported Outcome Questionnaire to Track Acute Toxicity in Patients Undergoing Pelvic Radiotherapy for Gynecologic Cancers.

Chan M, Olson R, Lapointe V, Hamm J, Bachand F, Holloway C, Parsons C, Lim P. Chan M, et al. Among authors: lapointe v. Curr Oncol. 2022 May 5;29(5):3306-3317. doi: 10.3390/curroncol29050270. Curr Oncol. 2022. PMID: 35621660 Free PMC article.

2

Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System.

Olson RA, LaPointe V, Benny A, Chan M, Lefresne S, McKenzie M. Olson RA, et al. Among authors: lapointe v. Curr Oncol. 2022 Mar 18;29(3):2073-2080. doi: 10.3390/curroncol29030167. Curr Oncol. 2022. PMID: 35323367 Free PMC article.

3

Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer.

Hamilton SN, Tran E, Ho C, Berthelet E, Wu J, DeVries K, LaPointe V, Bowman A, Lagman M, Olson R. Hamilton SN, et al. Among authors: lapointe v. Support Care Cancer. 2021 May;29(5):2537-2547. doi: 10.1007/s00520-020-05778-2. Epub 2020 Sep 19. Support Care Cancer. 2021. PMID: 32949298

4

Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort.

Conway JL, Yurkowski E, Glazier J, Gentles Q, Walter A, Bowering G, Curtis S, Schellenberg D, Halperin R, Lapointe V, Beckham W, Olivotto IA, Olson RA. Conway JL, et al. Among authors: lapointe v. Radiother Oncol. 2016 May;119(2):202-7. doi: 10.1016/j.radonc.2016.03.025. Epub 2016 Apr 9. Radiother Oncol. 2016. PMID: 27072939

5

Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research.

Olson RA, Howard F, Lapointe V, Schellenberg D, Nichol A, Bowering G, Curtis S, Walter A, Brown S, Thompson C, Bergin J, Lomas S, French J, Halperin R, Tyldesley S, Beckham W. Olson RA, et al. Among authors: lapointe v. Healthc Manage Forum. 2018 Jan;31(1):13-17. doi: 10.1177/0840470417715478. Healthc Manage Forum. 2018. PMID: 29264976

6

Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic.

Hamilton SN, Chau N, Berthelet E, Wu J, Tran E, Chevrier M, Lau V, Chan M, DeVries K, LaPointe V, Olson RA. Hamilton SN, et al. Among authors: lapointe v. Support Care Cancer. 2022 Mar;30(3):2745-2753. doi: 10.1007/s00520-021-06703-x. Epub 2021 Nov 26. Support Care Cancer. 2022. PMID: 34825983 Free PMC article.

7

Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC.

Sit D, Bale M, Lapointe V, Olson R, Hsu F. Sit D, et al. Among authors: lapointe v. JTO Clin Res Rep. 2022 Jun 24;3(8):100371. doi: 10.1016/j.jtocrr.2022.100371. eCollection 2022 Aug. JTO Clin Res Rep. 2022. PMID: 35941996 Free PMC article.

8

Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer.

Parimi S, Bondy S, Tsang E, McKenzie MR, Bachand F, Aparicio M, Duncan G, Sunderland K, Olson RA, Pai HH, Alexander AS, LaPointe V, Chi KN, Tyldesley S. Parimi S, et al. Among authors: lapointe v. Can Urol Assoc J. 2019 Oct;13(10):E311-E316. doi: 10.5489/cuaj.5685. Can Urol Assoc J. 2019. PMID: 31364977 Free PMC article.

9

The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy.

Herbert C, Morris WJ, Hamm J, Lapointe V, McKenzie M, Pickles T, Spadinger I, Keyes M. Herbert C, et al. Among authors: lapointe v. Brachytherapy. 2011 Nov-Dec;10(6):442-8. doi: 10.1016/j.brachy.2011.01.011. Epub 2011 Mar 12. Brachytherapy. 2011. PMID: 21398190

10

Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: a population-based cohort study.

Herbert C, Morris WJ, Keyes M, Hamm J, Lapointe V, McKenzie M, Pickles T, Spadinger I. Herbert C, et al. Among authors: lapointe v. Radiother Oncol. 2012 May;103(2):228-32. doi: 10.1016/j.radonc.2012.01.006. Epub 2012 Feb 10. Radiother Oncol. 2012. PMID: 22326573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page